Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 106, Issue 12, Pages 1926-1933
Publisher
Springer Nature
Online
2012-05-18
DOI
10.1038/bjc.2012.184
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6
- (2011) J P B O'Connor et al. BRITISH JOURNAL OF CANCER
- The role of bevacizumab in colorectal cancer: understanding its benefits and limitations
- (2011) Karen Mulder et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis
- (2011) Yoshinori Hirashima et al. INTERNATIONAL JOURNAL OF CANCER
- Use of Dynamic Contrast-enhanced MR Imaging to Predict Survival in Patients with Primary Breast Cancer Undergoing Neoadjuvant Chemotherapy
- (2011) Sonia P. Li et al. RADIOLOGY
- Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma
- (2010) Keith T. Flaherty et al. CANCER BIOLOGY & THERAPY
- An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer
- (2010) Sotirios Bisdas et al. EUROPEAN RADIOLOGY
- Monitoring Response to Antiangiogenic Therapy in Non-Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI
- (2010) A. J. de Langen et al. JOURNAL OF NUCLEAR MEDICINE
- Noninvasive Monitoring of Therapy-Induced Microvascular Changes in a Pancreatic Cancer Model Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging with P846, a New Low-Diffusible Gadolinium-Based Contrast Agent
- (2010) Veerle F. Casneuf et al. RADIATION RESEARCH
- Dynamic contrast-enhanced magnetic resonance imaging of human cervical carcinoma xenografts: Pharmacokinetic analysis and correlation to tumor histomorphology
- (2010) Christine Ellingsen et al. RADIOTHERAPY AND ONCOLOGY
- Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis
- (2010) Prosanto Chaudhury et al. HPB
- Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer
- (2009) P. Bystrom et al. ANNALS OF ONCOLOGY
- Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival
- (2009) W. R. Jarnagin et al. ANNALS OF ONCOLOGY
- Clinical Significance of Microvessel Count in Patients with Metastatic Liver Cancer Originating from Colorectal Carcinoma
- (2009) Atsushi Nanashima et al. ANNALS OF SURGICAL ONCOLOGY
- Chemotherapy Response Monitoring of Colorectal Liver Metastases by Dynamic Gd-DTPA-Enhanced MRI Perfusion Parameters and 18F-FDG PET Metabolic Rate
- (2009) D. Vriens et al. JOURNAL OF NUCLEAR MEDICINE
- Long-Term Results of Two-Stage Hepatectomy for Irresectable Colorectal Cancer Liver Metastases
- (2008) Dennis A. Wicherts et al. ANNALS OF SURGERY
- Prospective Evaluation of Two-Stage Hepatectomy Combined with Selective Portal Vein Embolisation and Systemic Chemotherapy for Patients with Unresectable Bilobar Colorectal Liver Metastases
- (2008) V. Pamecha et al. DIGESTIVE SURGERY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis
- (2008) Tobias Bäuerle et al. EUROPEAN JOURNAL OF RADIOLOGY
- Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases
- (2008) Dan G. Blazer et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab, Capecitabine, and Oxaliplatin As Neoadjuvant Therapy for Patients With Potentially Curable Metastatic Colorectal Cancer
- (2008) Brigit Gruenberger et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
- (2008) Bernard Nordlinger et al. LANCET
- Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer
- (2007) L.F. de Geus-Oei et al. ANNALS OF ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started